WuXi Biologics (Cayman) Inc. (HKG:2269)
32.36
+0.82 (2.60%)
At close: Mar 27, 2026
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 133.89 billion as of March 27, 2026. Its market cap has increased by 38.75% in one year.
Market Cap
133.89B
Enterprise Value
126.28B
Revenue
24.25B
Ranking
n/a
PE Ratio
25.05
Stock Price
32.36
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 133.89B, an increase of 317.90%. That is a compound annual growth rate of 17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 133.89B | 3.02% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 245.81B |
| Innovent Biologics | 148.36B |
| Akeso | 116.43B |
| Sichuan Kelun-Biotech Biopharmaceutical | 106.71B |
| Sino Biopharmaceutical | 105.30B |
| RemeGen | 68.72B |
| 3SBio | 59.89B |
| Biocytogen Pharmaceuticals (Beijing) | 41.27B |